Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)

OBJECTIVE: To investigate the health-related quality of life (HRQOL) related to hyperthermic intraperitoneal chemotherapy (HIPEC) following primary or interval cytoreductive surgery for primary ovarian cancer. METHODS: Between 2010 and 2016, a total of 184 patients were randomly assigned to receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji Hyun, Lee, Dong-eun, Lee, Yumi, Ha, Hyeong In, Chang, Yoon Jung, Chang, Suk-Joon, Park, Sang-Yoon, Lim, Myong Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250851/
https://www.ncbi.nlm.nih.gov/pubmed/35712968
http://dx.doi.org/10.3802/jgo.2022.33.e54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250851/
https://www.ncbi.nlm.nih.gov/pubmed/35712968
http://dx.doi.org/10.3802/jgo.2022.33.e54

Ejemplares similares